Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jul 28, 12:56

BioNTech (BNTX) Expected to Release Quarterly Earnings on Tuesday

BioNTech SE
Webhose 2026 Jul 28, 00:30

Expanded mRNA Patent Suits Against Pfizer Involving BioNTech's LNP Technology Might Change The Case For Investing In BioNTech (BNTX)

BioNTech SE
Webhose 2026 Jul 27, 08:25

Hsbc Holdings PLC Sells 31,445 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Jul 26, 04:39

BioNTech (BNTX) Stock May Look Fully Priced As Pipeline Hopes Build

BioNTech SE
Webhose 2026 Jul 25, 07:58

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Consensus Rating of "Moderate Buy" by Brokerages

BioNTech SE
Webhose 2026 Jul 24, 07:23

Aristides Capital LLC Decreases Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Jul 23, 00:00

Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework

BioNTech SE
Webhose 2026 Jul 21, 10:45

BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026

BioNTech SE
Webhose 2026 Jul 21, 09:28

SEB Asset Management AB Buys Shares of 200,108 BioNTech SE Sponsored ADR $BNTX - Zolmax

BioNTech SE
Webhose 2026 Jul 21, 09:28

SEB Asset Management AB Buys New Holdings in BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2026 Jul 21, 07:21

BioNTech SE Sponsored ADR $BNTX Shares Sold by Baader Bank Aktiengesellschaft

BioNTech SE
Webhose 2026 Jul 20, 06:29

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Analysts

BioNTech SE
Webhose 2026 Jul 20, 06:18

BioNTech (NASDAQ:BNTX) Stock Rating Upgraded by Wall Street Zen - Markets Daily

BioNTech SE
Webhose 2026 Jul 19, 06:22

BioNTech (BNTX) Faces Fresh Patent Lawsuits, Is The Valuation Gap Too Wide?

BioNTech SE
Webhose 2026 Jul 18, 23:36

BioNTech (NASDAQ:BNTX) Rating Increased to Hold at Wall Street Zen - Daily Political

BioNTech SE
Webhose 2026 Jul 18, 05:18

BioNTech (NASDAQ:BNTX) Upgraded to Hold at Wall Street Zen

BioNTech SE
Webhose 2026 Jul 18, 01:23

How Investors Are Reacting To BioNTech (BNTX) Expanded Global Patent Suits Targeting Its mRNA COVID-19 Vaccines

BioNTech SE
Webhose 2026 Jul 16, 13:07

Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech - Update | Morningstar

BioNTech SE
Webhose 2026 Jul 16, 00:00

BioNTech comes to Jerusalem: Mayor Moshe Lion announces new mRNA vaccine center

BioNTech SE
Webhose 2026 Jul 15, 00:00

Pfizer vaccine generates strong immune response in children under 5

BioNTech SE
Webhose 2026 Jul 15, 00:00

Pfizer says vaccine is 100% effective in protecting adolescents

BioNTech SE
Webhose 2026 Jul 11, 13:36

Candriam S.C.A. Lowers Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Jul 11, 06:25

BioNTech (BNTX) Could Be 82% Undervalued On Its Manufacturing Reset

BioNTech SE
Webhose 2026 Jul 10, 12:15

BioNTech (BNTX) Stock Could Be Overvalued After a 58% Five Year Slump

BioNTech SE
Webhose 2026 Jul 10, 07:35

Hsbc Holdings PLC Makes New $4.97 Million Investment in BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2026 Jul 09, 04:05

Cathie Wood Buys More SpaceX, Sells AMD, BioNTech, and Other Growth Stocks, 7/9/26

BioNTech SE
Webhose 2026 Jul 08, 14:33

BioNTech and Pfizer secure big European win over mRNA patent

BioNTech SE
Webhose 2026 Jul 06, 14:34

10 Newly Overvalued Stocks this Week | Morningstar

BioNTech SE
Webhose 2026 Jul 05, 05:28

BioNTech (BNTX) Is Up 6.9% After Moving To Exit German Manufacturing Sites Has The Bull Case Changed?

BioNTech SE
Webhose 2026 Jul 04, 08:48

Pictet Asset Management Holding SA Boosts Stake in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Jul 03, 11:29

BioNTech in Talks to Sell German Sites Amid Planned Closures, ETPharma

BioNTech SE
Webhose 2026 Jul 02, 00:00

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years

BioNTech SE
Webhose 2026 Jul 01, 09:45

mRNA Cancer Vaccine Market to Surpass $1.20 Billion in 2026 as Personalized Oncology Immunotherapies Advance, New Report Finds

BioNTech SE
Webhose 2026 Jun 30, 00:00

Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer

BioNTech SE

BioNTech News

USD to JPY exchange rate today
Daniel Carter 2026 Jul 28, 16:03

USD to JPY Forecast 2026: Will the US Dollar Rise or Fall Against the Japanese Yen?

forex
sandisk-stock
Julian Parker 2026 Jul 27, 16:04

SNDK Stock Forecast 2026–2030: Can SanDisk Keep Rising?

nio-stock
Julian Parker 2026 Jul 27, 16:03

NIO Stock Price Forecast 2030: Bull, Base and Bear Scenarios

XRP price prediction
Daniel Carter 2026 Jul 27, 16:03

XRP Price Prediction 2026, 2027, 2030 & 2040 | How High Can XRP Go?

crypto
eur to usd exchange rate today
Daniel Carter 2026 Jul 27, 16:03

EUR/USD Forecast 2026 & Beyond: Will the US Dollar Strengthen Against the Euro?

forex
apple-stock
Julian Parker 2026 Jul 26, 16:05

Apple Q3 2026 Earnings Preview: What Traders Need to Know

spacex
Julian Parker 2026 Jul 23, 16:01

Why Is SpaceX Stock Falling? Inside SPCX’s 48% Post-IPO Collapse

google-stock
Julian Parker 2026 Jul 22, 16:01

Alphabet (GOOGL) Stock Forecast 2026–2030: Where Could Google Stock Go as AI Spending Accelerates?

US Dollar Forecast 2026
Daniel Carter 2026 Jul 19, 16:03

US Dollar Forecast 2026 (H2 Outlook): Will the USD Stay Strong Through Year-End?

forex
Markets.com Demo Account
Daniel Carter 2026 Jul 19, 16:02

How to Open a Markets.com Demo Account? | 2026 Guide

cfd trading

Latest news

Show more
gold
Julian Parker 2026 Jul 28, 16:05

Gold Price Today, July 29: Gold Holds Above $4,020 Ahead of Fed Decision

Fed Rate Decision
Daniel Carter 2026 Jul 28, 16:03

Fed Rate Decision Preview July 30: Wall Street Braces for One of the Most Uncertain FOMC Meetings in Years

Julian Parker 2026 Jul 28, 16:03

Nikkei 225, Kospi Rebound as SK Hynix Earnings Lift Chip Stocks

nvda-stock
Julian Parker 2026 Jul 28, 16:03

Nvidia Stock Falls 5% on OpenAI Financing Fears

amazon
Daniel Carter 2026 Jul 28, 16:03

Amazon Earnings Date July 30: AWS Growth and $200 Billion AI Spending in Focus Ahead of Q2 Results

Stock
Julian Parker 2026 Jul 28, 16:03

Silver Price Rises Toward $57.80 Ahead of Fed Decision as Oil Rebounds

oil
Julian Parker 2026 Jul 28, 16:03

Oil Prices Jump Nearly 4% as Middle East Fighting Revives Supply Fears

sk-hynix
Daniel Carter 2026 Jul 28, 16:02

SK Hynix Q2 Earnings Miss Lofty Forecasts Despite Record Profit as HBM4 Ramps Up

Stock

Info

Spread

1.2805

Spread (%)

1.3801 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

23379148800

Shares Outstanding

252884261

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-5.77

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavirus and head and neck squamous cell carcinoma, as well as Pumitamig for metastatic colorectal and non-small cell lung cancer. In addition, the company engages in the development of oncology drugs under Phase II clinical trial comprising BNT116 for advance non-small cell lung cancer, BNT326/YL202 for multiple solid tumors and advanced/metastatic breast cancer, Autogene cevumeran for advance colorectal cancer, and Gotistobart for platinum-resistant ovarian cancer, as well as Pumitamig for glioblastoma, hepatocellular carcinoma, malignant pleural mesothelioma, neuroendocrine neoplasms, and metastatic pancreatic ductal adenocarcinoma. Further, it develops BNT166 which is Phase II clinical trial for mpox virus; and infectious diseases drugs under Phase 1/2 clinical trial, which include BNT162 + BNT161 for SARS-CoV-2 and influenza, BNT164 for tuberculosis, BNT165 for malaria, and BNT166 for mpox. The company was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
russell-2000-index
Julian Parker 2026 Jul 28, 16:03

Russell 2000 Index: What It Is and How to Trade It

how to invest in index funds
Daniel Carter 2026 Jul 28, 16:03

How to Invest in Index Funds: A Beginner's Guide [2026]

trade
Julian Parker 2026 Jul 28, 16:02

How to Create a Trading Plan: A Step-by-Step Guide

Trustpilot